Although it appears not to have a direct effect on CLL cells, the CCL2–CCR2 complex attracts more monocytes to the TME and stimulates the NLCs to release factors like BAFF and APRIL, building up the anti-apoptotic effect, tumor progression and metastasis [111,139]. Here, CCL2 is linked to B-cell chronic lymphocytic leukemia.